![Pierre Kyme](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 28 907 $ in data 30/06/2026
Pierre Kyme currently works at Special Phage Services Pty Ltd., as Director, Special Phage Holdings Pty Ltd., as Director, AmpliPhi Australia Pty Ltd., as Director, C3J Therapeutics, Inc., as Director-Product Development from 2012, and Armata Pharmaceuticals, Inc., as Chief Business Officer from 2024.
Dr. Kyme received his doctorate degree from The University of Sydney.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 17/04/2026 | 4.461 ( 0,01% ) | 28 907 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Public Communications Contact | - |
C3J Therapeutics, Inc.
 C3J Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel targeted antimicrobials-synthetic bacteriophage & antimicrobial peptides | Corporate Officer/Principal | 01/01/2012 |
AmpliPhi Australia Pty Ltd.
 AmpliPhi Australia Pty Ltd. Medical SpecialtiesHealth Technology Develops gene therapy products | Direttore/Membro del Consiglio | - |
Special Phage Holdings Pty Ltd.
 Special Phage Holdings Pty Ltd. Medical SpecialtiesHealth Technology Operates as a holding company with interests in phage therapy | Direttore/Membro del Consiglio | - |
Special Phage Services Pty Ltd.
 Special Phage Services Pty Ltd. Medical SpecialtiesHealth Technology Develops bacteriophage therapy services | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Special Phage Services Pty Ltd.
Special Phage Services Pty Ltd. Medical SpecialtiesHealth Technology Develops bacteriophage therapy services | Health Technology |
Special Phage Holdings Pty Ltd.
Special Phage Holdings Pty Ltd. Medical SpecialtiesHealth Technology Operates as a holding company with interests in phage therapy | Health Technology |
AmpliPhi Australia Pty Ltd.
AmpliPhi Australia Pty Ltd. Medical SpecialtiesHealth Technology Develops gene therapy products | Health Technology |
C3J Therapeutics, Inc.
C3J Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel targeted antimicrobials-synthetic bacteriophage & antimicrobial peptides | Health Technology |
Armata Pharmaceuticals, Inc.
 Armata Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on the development and commercialization of novel targeted antimicrobials | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
